Nebupent

Nebupent is a brand name of pentamidine, approved by the FDA in the following formulation(s):

NEBUPENT (pentamidine isethionate - for solution; inhalation)

• 
  Manufacturer: APP PHARMS
  
  Approval date: June 15, 1989
  
  Strength(s): 300MG/VIAL ^[RLD]

Has a generic version of Nebupent been approved?

No. There is currently no therapeutically equivalent version of Nebupent available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nebupent. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Nebupent.

See also...

• Nebupent Solution Consumer Information (Wolters Kluwer)
• Nebupent Consumer Information (Cerner Multum)
• Nebupent Advanced Consumer Information (Micromedex)
• Pentamidine Consumer Information (Wolters Kluwer)
• Pentamidine Solution Consumer Information (Wolters Kluwer)
• Pentamidine Consumer Information (Cerner Multum)
• Pentamidine Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Pentamidine Injection Advanced Consumer Information (Micromedex)
• Pentamidine Isethionate AHFS DI Monographs (ASHP)